Jerome J. Lande's most recent trade in Itron Inc. was a trade of 472 Common Stock done . Disclosure was reported to the exchange on April 1, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Itron Inc. | Jerome J. Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 472 | 8,224 (0%) | 0% | 0 | Common Stock | |
Itron Inc. | Jerome J. Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 460 | 7,752 (0%) | 0% | 0 | Common Stock | |
Itron Inc. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 475 | 7,292 (0%) | 0% | 0 | Common Stock | |
Itron Inc. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 509 | 6,817 (0%) | 0% | 0 | Common Stock | |
Conmed Corp. | Jerome J. Lande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 302 | 3,856 (0%) | 0% | 0 | Common Stock | |
Conmed Corp. | Jerome J. Lande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 302 | 0 | - | - | Rsus (restricted Stock Units) | |
Itron Inc. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 558 | 6,308 (0%) | 0% | 0 | Common Stock | |
Itron Inc. | Jerome J Lande | Director | Sale of securities on an exchange or to another person at price $ 95.32 per share. | 07 Mar 2024 | 6,007 | 5,750 (0%) | 0% | 95.3 | 572,595 | Common Stock |
Itron Inc. | Jerome J Lande | Director | Sale of securities on an exchange or to another person at price $ 95.50 per share. | 07 Mar 2024 | 5,720 | 14,926 (0%) | 0% | 95.5 | 546,260 | Common Stock |
Itron Inc. | Jerome J Lande | Director | Sale of securities on an exchange or to another person at price $ 94.68 per share. | 07 Mar 2024 | 3,169 | 11,757 (0%) | 0% | 94.7 | 300,040 | Common Stock |
Itron Inc. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 665 | 20,646 (0%) | 0% | 0 | Common Stock | |
Itron Inc. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 578 | 19,280 (0%) | 0% | 0 | Common Stock | |
Conmed Corp. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 2,826 | 2,826 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Jerome J Lande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 335 | 3,554 (0%) | 0% | 0 | Common Stock | |
Conmed Corp. | Jerome J Lande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 335 | 0 | - | - | Rsus (restricted Stock Units) | |
Conmed Corp. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 302 | 302 | - | - | Rsus (restricted Stock Units) | |
Itron Inc. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 745 | 18,702 (0%) | 0% | 0 | Common Stock | |
Itron Inc. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 797 | 17,955 (0%) | 0% | 0 | Common Stock | |
Itron Inc. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 937 | 17,158 (0%) | 0% | 0 | Common Stock | |
Itron Inc. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 851 | 16,221 (0%) | 0% | 0 | Common Stock | |
Conmed Corp. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,453 | 3,453 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Jerome J Lande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 812 | 0 | - | - | Rsus (restricted Stock Units) | |
Conmed Corp. | Jerome J Lande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 812 | 3,219 (0%) | 0% | 0 | Common Stock | |
Conmed Corp. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 335 | 335 | - | - | Rsus (restricted Stock Units) | |
Conmed Corp. | Jerome J Lande | Director | Sale of securities on an exchange or to another person at price $ 115.42 per share. | 13 May 2022 | 6,000 | 3,928 (0%) | 0% | 115.4 | 692,536 | Common Stock |
Conmed Corp. | Jerome J Lande | Director | Sale of securities on an exchange or to another person at price $ 117.00 per share. | 13 May 2022 | 1,521 | 2,407 (0%) | 0% | 117 | 177,957 | Common Stock |
Itron Inc. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 774 | 15,370 (0%) | 0% | 0 | Common Stock | |
Itron Inc. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 598 | 14,596 (0%) | 0% | 0 | Common Stock | |
Itron Inc. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 424 | 13,998 (0%) | 0% | 0 | Common Stock | |
Itron Inc. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 322 | 13,574 (0%) | 0% | 0 | Common Stock | |
Conmed Corp. | Jerome J Lande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 1,521 | 9,928 (0%) | 0% | 0 | Common Stock | |
Conmed Corp. | Jerome J Lande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 1,521 | 0 | - | - | Rsus (restricted Stock Units) | |
Conmed Corp. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 865 | 865 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 812 | 812 | - | - | Rsus (restricted Stock Units) | |
Itron Inc. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 358 | 13,252 (0%) | 0% | 0 | Common Stock | |
Itron Inc. | Jerome J Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 659 | 12,894 (0%) | 0% | 0 | Common Stock | |
Conmed Corp. | Jerome J. Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 1,843 | 1,843 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Jerome J. Lande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 1,521 | 1,521 | - | - | Rsus (restricted Stock Units) | |
Conmed Corp. | Jerome J. Lande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2020 | 1,407 | 0 | - | - | Rsus (restricted Stock Units) | |
Conmed Corp. | Jerome J. Lande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2020 | 1,407 | 8,407 (0%) | 0% | 0 | Common Stock |